Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 Work package
A work package focussed on the Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, made available on 11 December 2024, subject to the Made negative procedure. Scrutiny period described by Bicameral instruments (clock stops if both Houses rise).
There are 10 business items actualising 13 steps.
Business items which have happened
-
11 December 2024
-
1 January 2025
-
14 January 2025
-
5 February 2025
-
Considered by the Joint Committee on Statutory Instruments (JCSI) (House of Commons and House of Lords)
Instrument drawn to the special attention of the Houses by the Joint Committee on Statutory Instruments (JCSI) (House of Commons and House of Lords)
Joint Committee on Statutory Instruments (JCSI) draws the special attention of both Houses to this instrument on the grounds that it is defectively drafted (House of Commons and House of Lords)
-
Objection period ends
-
Instrument remains law
-
Procedure concluded in the House of Commons and the House of Lords (House of Commons and House of Lords)
-